<code id='FB2D33C4B4'></code><style id='FB2D33C4B4'></style>
    • <acronym id='FB2D33C4B4'></acronym>
      <center id='FB2D33C4B4'><center id='FB2D33C4B4'><tfoot id='FB2D33C4B4'></tfoot></center><abbr id='FB2D33C4B4'><dir id='FB2D33C4B4'><tfoot id='FB2D33C4B4'></tfoot><noframes id='FB2D33C4B4'>

    • <optgroup id='FB2D33C4B4'><strike id='FB2D33C4B4'><sup id='FB2D33C4B4'></sup></strike><code id='FB2D33C4B4'></code></optgroup>
        1. <b id='FB2D33C4B4'><label id='FB2D33C4B4'><select id='FB2D33C4B4'><dt id='FB2D33C4B4'><span id='FB2D33C4B4'></span></dt></select></label></b><u id='FB2D33C4B4'></u>
          <i id='FB2D33C4B4'><strike id='FB2D33C4B4'><tt id='FB2D33C4B4'><pre id='FB2D33C4B4'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:9
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Arena BioWorks launches in Cambridge to speed drug discovery
          Arena BioWorks launches in Cambridge to speed drug discovery

          DavidL.Ryan/BostonGlobeAteamofhigh-poweredscientistsandbillionaireinvestorssaidFridaythatthey’relaun

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Boston Scientific acquires urology company Axonics for $3.7 billion

          BostonScientificisgrowingitsurologyportfoliowiththeAxonicsacquisition.StevenSenne/APBostonScientific